RNVA — Rennova Health Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.04m
- $11.39m
- $18.69m
Annual balance sheet for Rennova Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.017 | 0.025 | 0.725 | 0.499 | 0.049 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.21 | 1.92 | 3.59 | 5.41 | 6.65 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5.35 | 2.72 | 4.72 | 6.36 | 6.94 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 8.51 | 8.81 | 5.45 | 4.77 | 4.68 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 14.7 | 12.3 | 19.6 | 20.6 | 20.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 83.4 | 59.2 | 46.4 | 49.3 | 42.5 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 91.2 | 61.3 | 46.9 | 49.7 | 57.1 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -76.5 | -49 | -27.3 | -29.1 | -36.8 |
| Total Liabilities & Shareholders' Equity | 14.7 | 12.3 | 19.6 | 20.6 | 20.3 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |